3 most recent filings and news items mentioning ENGN. Updated every 60 seconds.
curl "https://api.brieftape.com/v1/tickers/ENGN/news?limit=20"
Pull ENGN filings straight into your trading bot, model, or app.
Get an API key — free tier: 10,000 calls/dayenGene Therapeutics named Michael Heffernan chairman, replacing Dr. Richard Glickman, to better support commercial goals. The company outlined regulatory timelines including a planned BLA submission and potential 2027 approval for its NMIBC treatment.
View filing at SEC.gov →W.P. Carey To Rally Around 10%? Here Are 10 Top Analyst Forecasts For Tuesday
View filing at SEC.gov →enGene announced 54% complete response rate in LEGEND pivotal cohort and plans to initiate a Biologics License Application for detalimogene in the second half of 2026 pending FDA engagement. The company reduced workforce by 50% to preserve $285 million in cash and focus on regula
View filing at SEC.gov →